A 12-page Executive Summary offering summary highlights for 22 Accountable Care Organizations and ACO solutions companies regarding their successes during the most recent MSSP performance year.
Six Takeaways from CMS' 2023 Star Ratings
- 51% of MA plans with drug coverage will have a four-star rating or higher in 2023
- compared with 68% for 2022.
- 72% of people currently in an MA drug coverage plan are enrolled in one with four stars or higher
- compared to 90% for 2022.
- 31% of standalone Part D plans active in 2023 received a star rating of four or more - about 9% of part D plan enrollees are currently in such a plan.
- 62 contracts have five stars
- with 57 of them as MA prescription drug offerings.
- Approximately 72% of the non-profit contracts received 4 or more stars compared to 43% of the for-profit MA-PDs.
- Approximately 42% of nonprofit PDPs received 4 or more stars compared to 25% of the for-profit PDPs.
Source: CMS, October 6, 2022 - https://healthsprocket.com/hs/content/six-takeaways-cms-2023-star-ratings